Joint Conference and Workshops
The AACR worked with cancer research organizations around the world to produce the following joint conferences, educational workshops, and symposia in 2022:
ANNUAL SYMPOSIUM ON GLOBAL CANCER RESEARCH
March 23–24; Virtual
The 10th edition of this symposium was held as a satellite meeting to the 13th annual conference of the Consortium of Universities for Global Health. The AACR organized the meeting in collaboration with the U.S. NCI Center for Global Health (CGH), the American Society of Clinical Oncology, the USC Norris Comprehensive Cancer Center, the UCLA Jonsson Comprehensive Cancer Center, Partners in Hope Malawi, the City of Hope Comprehensive Cancer Center, Fundación Instituto Leloir-CONICET, and the Republic of Zambia Ministry of Health.
The theme of the symposium was “New Models for Global Cancer Research, Training, and Control.” Over the course of two days, the organizers and attendees identified more effective ways to foster collaboration and the exchange of information among the global research community; developed strategic priorities for advancing the field of global oncology; and showcased initiatives that are reducing the burden of cancer in low resource settings.
SEVENTH JCA-AACR SPECIAL JOINT CONFERENCE ON THE LATEST ADVANCES IN PANCREATIC CANCER RESEARCH: FROM BASIC SCIENCE TO THERAPEUTICS
July 8–10, 2022; Kyoto, Japan
The AACR partnered with the Japanese Cancer Association (JCA) to present the seventh edition of this vital conference, which was developed by Organizing Committee members Kohei Miyazono, PhD, Masanobu Oshima, PhD, and Hiroshi Seno, MD, PhD, of the JCA and Elizabeth M. Jaffee, MD, FAACR, Anirban Maitra, MBBS, and Rosalie C. Sears, PhD, of the AACR. The conference brought together basic scientists and clinical researchers from the United States, Japan, and around the world to share the latest developments in pancreatic cancer research.
EORTC-NCI-AACR MOLECULAR TARGETS AND CANCER THERAPEUTICS SYMPOSIUM
October 26–28, 2022; Barcelona, Spain
Ruth Plummer, MBE, FMedSci, James L. Gulley, MD, PhD, and Lillian L. Siu, MD, chaired the 34th edition of this vital symposium, which is organized jointly by the European Organization for the Research and Treatment of Cancer (EORTC), the NCI, and the AACR. Widely considered to be the premier drug development and translational research meeting, the symposium focused on preclinical and phase I studies and showcased the latest cutting-edge discoveries in molecular biology.